Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Covington
Fuji
McKinsey
Moodys
Harvard Business School
Cantor Fitzgerald
Teva
US Department of Justice

Generated: April 26, 2018

DrugPatentWatch Database Preview

Ganciclovir - Generic Drug Details

« Back to Dashboard

What are the generic sources for ganciclovir and what is the scope of ganciclovir freedom to operate?

Ganciclovir
is the generic ingredient in five branded drugs marketed by Roche Palo, Ranbaxy Labs Ltd, Bausch And Lomb, Exela Pharma Scs Llc, Fresenius Kabi Usa, Luitpold Pharms Inc, Mylan Labs Ltd, Par Sterile Products, Pharmascience Inc, and West-ward Pharms Int, and is included in twelve NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for ganciclovir. Four suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for ganciclovir
Synonyms for ganciclovir
02L083W284
107910-75-8
6H-Purin-6-one, 1,9-dihydro-2-amino-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, monosodium salt
6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, monosodium salt
6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, sodium salt
82410-32-0 (Parent)
84245-13-6
9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, monosodium salt
AB0016776
AC1Q1VAA
AKOS015896059
API0024397
BS-1004
C9H12N5NaO4
CHEMBL1200850
Cytovene IV
Cytovene IV (TN)
D04301
FT-0656038
GANCICLOVIR SODIUM
Ganciclovir sodium (unspecified MF)
Ganciclovir sodium (USAN)
Ganciclovir sodium [USAN]
Ganciclovir Sodium Salt
HE004149
I06-1697
J-002034
JJICLMJFIKGAAU-UHFFFAOYSA-M
K-0587
KS-00002WRY
MFCD00873979
MolPort-020-313-387
Natclovir
P006
RS 21592 Sodium
RS-21592 sodium
SC-47228
SCHEMBL149822
Sodium 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6H-purin-6-one
sodium 2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-9H-purin-6-olate
sodium 2-amino-9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}-9h-purin-6-olate
ST51053198
UNII-02L083W284

US Patents and Regulatory Information for ganciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmascience Inc GANCICLOVIR SODIUM ganciclovir sodium INJECTABLE;INJECTION 207645-001 Dec 8, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bausch And Lomb ZIRGAN ganciclovir GEL;OPHTHALMIC 022211-001 Sep 15, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy Labs Ltd GANCICLOVIR ganciclovir CAPSULE;ORAL 076457-002 Jun 27, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold Pharms Inc GANCICLOVIR ganciclovir sodium INJECTABLE;INJECTION 202624-001 Sep 18, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ganciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch And Lomb VITRASERT ganciclovir IMPLANT;IMPLANTATION 020569-001 Mar 4, 1996 ➤ Sign Up ➤ Sign Up
Roche Palo CYTOVENE ganciclovir CAPSULE;ORAL 020460-002 Dec 12, 1997 ➤ Sign Up ➤ Sign Up
Roche Palo CYTOVENE ganciclovir CAPSULE;ORAL 020460-001 Dec 22, 1994 ➤ Sign Up ➤ Sign Up
Roche Palo CYTOVENE ganciclovir CAPSULE;ORAL 020460-001 Dec 22, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
UBS
Fish and Richardson
McKinsey
Daiichi Sankyo
QuintilesIMS
Federal Trade Commission
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.